Global Next-Generation Breast Cancer Diagnostic and Screening Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size 2017-2028

2.1.2 Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Next-Generation Breast Cancer Diagnostic and Screening Segment by Type

2.2.1 Real-Time PCR (q-PCR)

2.2.2 Immunohistochemistry (IHC)

2.2.3 Next-Generation Sequencing (NGS)

2.2.4 Fluorescent In-Situ Hybridization (FISH)

2.3 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type

2.3.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2017-2022)

2.4 Next-Generation Breast Cancer Diagnostic and Screening Segment by Application

2.4.1 Hospital-associated Labs

2.4.2 Cancer Research Institutes

2.4.3 Diagnostic Centers

2.5 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application

2.5.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2017-2022)

3 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Player

3.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Players

3.1.1 Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Players (2020-2022)

3.1.2 Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Players (2020-2022)

3.2 Global Next-Generation Breast Cancer Diagnostic and Screening Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Next-Generation Breast Cancer Diagnostic and Screening by Regions

4.1 Next-Generation Breast Cancer Diagnostic and Screening Market Size by Regions (2017-2022)

4.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2017-2022)

4.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2017-2022)

4.4 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2017-2022)

4.5 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth (2017-2022)

5 Americas

5.1 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2017-2022)

5.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022)

5.3 Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2017-2022)

6.2 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022)

6.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Next-Generation Breast Cancer Diagnostic and Screening by Country (2017-2022)

7.2 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022)

7.3 Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening by Region (2017-2022)

8.2 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022)

8.3 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.1 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Regions (2023-2028)

10.1.1 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Regions (2023-2028)

10.1.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Forecast

10.1.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Forecast

10.1.4 Europe Next-Generation Breast Cancer Diagnostic and Screening Forecast

10.1.5 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Forecast

10.2 Americas Next-Generation Breast Cancer Diagnostic and Screening Forecast by Country (2023-2028)

10.2.1 United States Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.2.2 Canada Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.2.3 Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.2.4 Brazil Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.3 APAC Next-Generation Breast Cancer Diagnostic and Screening Forecast by Region (2023-2028)

10.3.1 China Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.3.2 Japan Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.3.3 Korea Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.3.4 Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.3.5 India Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.3.6 Australia Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.4 Europe Next-Generation Breast Cancer Diagnostic and Screening Forecast by Country (2023-2028)

10.4.1 Germany Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.4.2 France Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.4.3 UK Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.4.4 Italy Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.4.5 Russia Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.5 Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Forecast by Region (2023-2028)

10.5.1 Egypt Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.5.2 South Africa Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.5.3 Israel Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.5.4 Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.5.5 GCC Countries Next-Generation Breast Cancer Diagnostic and Screening Market Forecast

10.6 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Type (2023-2028)

10.7 Global Next-Generation Breast Cancer Diagnostic and Screening Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Information

11.1.2 Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.1.3 Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Abbott Laboratories Main Business Overview

11.1.5 Abbott Laboratories Latest Developments

11.2 Agendia

11.2.1 Agendia Company Information

11.2.2 Agendia Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.2.3 Agendia Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Agendia Main Business Overview

11.2.5 Agendia Latest Developments

11.3 Agilent Technologies

11.3.1 Agilent Technologies Company Information

11.3.2 Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.3.3 Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Agilent Technologies Main Business Overview

11.3.5 Agilent Technologies Latest Developments

11.4 Ambry Genetics

11.4.1 Ambry Genetics Company Information

11.4.2 Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.4.3 Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Ambry Genetics Main Business Overview

11.4.5 Ambry Genetics Latest Developments

11.5 Biocept

11.5.1 Biocept Company Information

11.5.2 Biocept Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.5.3 Biocept Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Biocept Main Business Overview

11.5.5 Biocept Latest Developments

11.6 Biotheranostics

11.6.1 Biotheranostics Company Information

11.6.2 Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.6.3 Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Biotheranostics Main Business Overview

11.6.5 Biotheranostics Latest Developments

11.7 Centogene

11.7.1 Centogene Company Information

11.7.2 Centogene Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.7.3 Centogene Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Centogene Main Business Overview

11.7.5 Centogene Latest Developments

11.8 Danaher Corporation

11.8.1 Danaher Corporation Company Information

11.8.2 Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.8.3 Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Danaher Corporation Main Business Overview

11.8.5 Danaher Corporation Latest Developments

11.9 EXACT Sciences Corporation

11.9.1 EXACT Sciences Corporation Company Information

11.9.2 EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.9.3 EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 EXACT Sciences Corporation Main Business Overview

11.9.5 EXACT Sciences Corporation Latest Developments

11.10 Roche Holding AG

11.10.1 Roche Holding AG Company Information

11.10.2 Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.10.3 Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Roche Holding AG Main Business Overview

11.10.5 Roche Holding AG Latest Developments

11.11 Fulgent Genetics

11.11.1 Fulgent Genetics Company Information

11.11.2 Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.11.3 Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Fulgent Genetics Main Business Overview

11.11.5 Fulgent Genetics Latest Developments

11.12 Illumina

11.12.1 Illumina Company Information

11.12.2 Illumina Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.12.3 Illumina Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Illumina Main Business Overview

11.12.5 Illumina Latest Developments

11.13 Invitae

11.13.1 Invitae Company Information

11.13.2 Invitae Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.13.3 Invitae Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Invitae Main Business Overview

11.13.5 Invitae Latest Developments

11.14 Lucence Diagnostics Pte Ltd

11.14.1 Lucence Diagnostics Pte Ltd Company Information

11.14.2 Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.14.3 Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Lucence Diagnostics Pte Ltd Main Business Overview

11.14.5 Lucence Diagnostics Pte Ltd Latest Developments

11.15 Myriad Genetics

11.15.1 Myriad Genetics Company Information

11.15.2 Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

11.15.3 Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Myriad Genetics Main Business Overview

11.15.5 Myriad Genetics Latest Developments

12 Research Findings and Conclusion

Table 1. Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Real-Time PCR (q-PCR)

Table 3. Major Players of Immunohistochemistry (IHC)

Table 4. Major Players of Next-Generation Sequencing (NGS)

Table 5. Major Players of Fluorescent In-Situ Hybridization (FISH)

Table 6. Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2017-2022)

Table 9. Next-Generation Breast Cancer Diagnostic and Screening Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2017-2022)

Table 12. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Player (2020-2022)

Table 14. Next-Generation Breast Cancer Diagnostic and Screening Key Players Head office and Products Offered

Table 15. Next-Generation Breast Cancer Diagnostic and Screening Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Regions (2017-2022)

Table 20. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Country (2017-2022)

Table 22. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2017-2022)

Table 24. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2017-2022)

Table 26. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region (2017-2022)

Table 28. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2017-2022)

Table 30. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2017-2022)

Table 32. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Country (2017-2022)

Table 34. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2017-2022)

Table 36. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Next-Generation Breast Cancer Diagnostic and Screening

Table 45. Key Market Challenges & Risks of Next-Generation Breast Cancer Diagnostic and Screening

Table 46. Key Industry Trends of Next-Generation Breast Cancer Diagnostic and Screening

Table 47. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share Forecast by Application (2023-2028)

Table 53. Abbott Laboratories Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 54. Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 55. Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Abbott Laboratories Main Business

Table 57. Abbott Laboratories Latest Developments

Table 58. Agendia Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 59. Agendia Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 60. Agendia Main Business

Table 61. Agendia Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Agendia Latest Developments

Table 63. Agilent Technologies Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 64. Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 65. Agilent Technologies Main Business

Table 66. Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Agilent Technologies Latest Developments

Table 68. Ambry Genetics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 69. Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 70. Ambry Genetics Main Business

Table 71. Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Ambry Genetics Latest Developments

Table 73. Biocept Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 74. Biocept Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 75. Biocept Main Business

Table 76. Biocept Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Biocept Latest Developments

Table 78. Biotheranostics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 79. Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 80. Biotheranostics Main Business

Table 81. Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Biotheranostics Latest Developments

Table 83. Centogene Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 84. Centogene Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 85. Centogene Main Business

Table 86. Centogene Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Centogene Latest Developments

Table 88. Danaher Corporation Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 89. Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 90. Danaher Corporation Main Business

Table 91. Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Danaher Corporation Latest Developments

Table 93. EXACT Sciences Corporation Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 94. EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 95. EXACT Sciences Corporation Main Business

Table 96. EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. EXACT Sciences Corporation Latest Developments

Table 98. Roche Holding AG Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 99. Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 100. Roche Holding AG Main Business

Table 101. Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Roche Holding AG Latest Developments

Table 103. Fulgent Genetics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 104. Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 105. Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Fulgent Genetics Main Business

Table 107. Fulgent Genetics Latest Developments

Table 108. Illumina Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 109. Illumina Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 110. Illumina Main Business

Table 111. Illumina Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Illumina Latest Developments

Table 113. Invitae Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 114. Invitae Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 115. Invitae Main Business

Table 116. Invitae Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Invitae Latest Developments

Table 118. Lucence Diagnostics Pte Ltd Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 119. Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 120. Lucence Diagnostics Pte Ltd Main Business

Table 121. Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. Lucence Diagnostics Pte Ltd Latest Developments

Table 123. Myriad Genetics Details, Company Type, Next-Generation Breast Cancer Diagnostic and Screening Area Served and Its Competitors

Table 124. Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Product Offered

Table 125. Myriad Genetics Main Business

Table 126. Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 127. Myriad Genetics Latest Developments

List of Figures

Figure 1. Next-Generation Breast Cancer Diagnostic and Screening Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type in 2021

Figure 7. Next-Generation Breast Cancer Diagnostic and Screening in Hospital-associated Labs

Figure 8. Global Next-Generation Breast Cancer Diagnostic and Screening Market: Hospital-associated Labs (2017-2022) & ($ Millions)

Figure 9. Next-Generation Breast Cancer Diagnostic and Screening in Cancer Research Institutes

Figure 10. Global Next-Generation Breast Cancer Diagnostic and Screening Market: Cancer Research Institutes (2017-2022) & ($ Millions)

Figure 11. Next-Generation Breast Cancer Diagnostic and Screening in Diagnostic Centers

Figure 12. Global Next-Generation Breast Cancer Diagnostic and Screening Market: Diagnostic Centers (2017-2022) & ($ Millions)

Figure 13. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application in 2021

Figure 14. Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share by Player in 2021

Figure 15. Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size 2017-2022 ($ Millions)

Figure 17. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size 2017-2022 ($ Millions)

Figure 18. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size 2017-2022 ($ Millions)

Figure 20. Americas Next-Generation Breast Cancer Diagnostic and Screening Value Market Share by Country in 2021

Figure 21. Americas Next-Generation Breast Cancer Diagnostic and Screening Consumption Market Share by Type in 2021

Figure 22. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application in 2021

Figure 23. United States Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region in 2021

Figure 28. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application in 2021

Figure 29. China Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Country in 2021

Figure 36. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type in 2021

Figure 37. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application in 2021

Figure 38. Germany Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Market Share by Application in 2021

Figure 46. Egypt Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Next-Generation Breast Cancer Diagnostic and Screening Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 52. APAC Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 53. Europe Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 55. United States Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 56. Canada Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 59. China Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 60. Japan Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 61. Korea Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 63. India Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 64. Australia Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 65. Germany Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 66. France Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 67. UK Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 68. Italy Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 69. Russia Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 70. Spain Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 73. Israel Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Next-Generation Breast Cancer Diagnostic and Screening Market Size 2023-2028 ($ Millions)